0.90 USD
▲+0.09+11.12%
盘后 0.90 -0.01%
2026-11-20
市值
$39.96M
市盈率
0.78
EPS
1.15
股息率
—
52 周区间
0.50 – 1.39
成交量
83.88K
Beta
0.92
目标价
—
52W 低 0.5052W 高 1.39
价格走势
公司简介
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac pat...